PubMed:9341151
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-73 | Sentence | denotes | Purification and characterization of the human SR 31747A-binding protein. |
| T2 | 74-135 | Sentence | denotes | A nuclear membrane protein related to yeast sterol isomerase. |
| T3 | 136-266 | Sentence | denotes | SR 31747A, defined as a sigma ligand, is a novel immunosuppressive agent that blocks proliferation of human and mouse lymphocytes. |
| T4 | 267-391 | Sentence | denotes | Using a radiolabeled chemical probe, we here purified a target of SR 31747A and called it SR 31747A-binding protein (SR-BP). |
| T5 | 392-501 | Sentence | denotes | Purified SR-BP retained its binding properties and migrated on SDS-polyacrylamide gel as a Mr 28,000 protein. |
| T6 | 502-661 | Sentence | denotes | Cloning of the cDNA encoding human SR-BP shows an open reading frame for a 223-amino acid protein, which is homologous to the recently cloned sigma 1 receptor. |
| T7 | 662-792 | Sentence | denotes | Interestingly, the deduced amino acid sequence was found to be related to fungal C8-C7 sterol isomerase, encoded by the ERG2 gene. |
| T8 | 793-942 | Sentence | denotes | The ERG2 gene product has been identified recently as the molecular target of SR 31747A that mediates antiproliferative effects of the drug in yeast. |
| T9 | 943-1146 | Sentence | denotes | Northern blot analysis of SR-BP gene expression revealed a single transcript of 2 kilobases which was widely expressed among organs, with the highest abundance in liver and the lowest abundance in brain. |
| T10 | 1147-1330 | Sentence | denotes | Subcellular localization analysis in various cells, using a specific monoclonal antibody raised against SR-BP, demonstrated that this protein was associated with the nuclear envelope. |
| T11 | 1331-1616 | Sentence | denotes | When studying the binding of SR 31747A on membranes from yeast expressing SR-BP, we found a pharmacological profile of sigma 1 receptors; binding was displaced by (+)-pentazocine, haloperidol, and (+)-SKF 10,047, with (+)-SKF 10, 047 being a more potent competitor than (-)-SKF 10,047. |
| T12 | 1617-1813 | Sentence | denotes | Scatchard plot analysis revealed Kd values of 7.1 nM and 0.15 nM for (+)-pentazocine and SR 31747A, respectively, indicating an affinity of SR-BP 50-fold higher for SR 31747A than for pentazocine. |
| T13 | 1814-1958 | Sentence | denotes | Additionally, we showed that pentazocine, a competitive inhibitor of SR 31747A binding, also prevents the immunosuppressive effect of SR 31747A. |
| T14 | 1959-2135 | Sentence | denotes | Taken together, these findings strongly suggest that SR-BP represents the molecular target for SR 31747A in mammalian tissues, which could be critical for T cell proliferation. |
| T1 | 0-73 | Sentence | denotes | Purification and characterization of the human SR 31747A-binding protein. |
| T2 | 74-135 | Sentence | denotes | A nuclear membrane protein related to yeast sterol isomerase. |
| T3 | 136-266 | Sentence | denotes | SR 31747A, defined as a sigma ligand, is a novel immunosuppressive agent that blocks proliferation of human and mouse lymphocytes. |
| T4 | 267-391 | Sentence | denotes | Using a radiolabeled chemical probe, we here purified a target of SR 31747A and called it SR 31747A-binding protein (SR-BP). |
| T5 | 392-501 | Sentence | denotes | Purified SR-BP retained its binding properties and migrated on SDS-polyacrylamide gel as a Mr 28,000 protein. |
| T6 | 502-661 | Sentence | denotes | Cloning of the cDNA encoding human SR-BP shows an open reading frame for a 223-amino acid protein, which is homologous to the recently cloned sigma 1 receptor. |
| T7 | 662-792 | Sentence | denotes | Interestingly, the deduced amino acid sequence was found to be related to fungal C8-C7 sterol isomerase, encoded by the ERG2 gene. |
| T8 | 793-942 | Sentence | denotes | The ERG2 gene product has been identified recently as the molecular target of SR 31747A that mediates antiproliferative effects of the drug in yeast. |
| T9 | 943-1146 | Sentence | denotes | Northern blot analysis of SR-BP gene expression revealed a single transcript of 2 kilobases which was widely expressed among organs, with the highest abundance in liver and the lowest abundance in brain. |
| T10 | 1147-1330 | Sentence | denotes | Subcellular localization analysis in various cells, using a specific monoclonal antibody raised against SR-BP, demonstrated that this protein was associated with the nuclear envelope. |
| T11 | 1331-1616 | Sentence | denotes | When studying the binding of SR 31747A on membranes from yeast expressing SR-BP, we found a pharmacological profile of sigma 1 receptors; binding was displaced by (+)-pentazocine, haloperidol, and (+)-SKF 10,047, with (+)-SKF 10, 047 being a more potent competitor than (-)-SKF 10,047. |
| T12 | 1617-1813 | Sentence | denotes | Scatchard plot analysis revealed Kd values of 7.1 nM and 0.15 nM for (+)-pentazocine and SR 31747A, respectively, indicating an affinity of SR-BP 50-fold higher for SR 31747A than for pentazocine. |
| T13 | 1814-1958 | Sentence | denotes | Additionally, we showed that pentazocine, a competitive inhibitor of SR 31747A binding, also prevents the immunosuppressive effect of SR 31747A. |
| T14 | 1959-2135 | Sentence | denotes | Taken together, these findings strongly suggest that SR-BP represents the molecular target for SR 31747A in mammalian tissues, which could be critical for T cell proliferation. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1106-1111 | http://purl.obolibrary.org/obo/MAT_0000097 | denotes | liver |
| T2 | 1140-1145 | http://purl.obolibrary.org/obo/MAT_0000098 | denotes | brain |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 41-72 | protein | denotes | human SR 31747A-binding protein |
| T2 | 76-100 | protein | denotes | nuclear membrane protein |
| T3 | 112-134 | protein | denotes | yeast sterol isomerase |
| T4 | 238-265 | cell_type | denotes | human and mouse lymphocytes |
| T5 | 357-382 | protein | denotes | SR 31747A-binding protein |
| T6 | 384-389 | protein | denotes | SR-BP |
| T7 | 392-406 | protein | denotes | Purified SR-BP |
| T8 | 483-500 | protein | denotes | Mr 28,000 protein |
| T9 | 517-521 | DNA | denotes | cDNA |
| T10 | 531-542 | protein | denotes | human SR-BP |
| T11 | 552-570 | DNA | denotes | open reading frame |
| T12 | 577-599 | protein | denotes | 223-amino acid protein |
| T13 | 644-660 | protein | denotes | sigma 1 receptor |
| T14 | 736-765 | protein | denotes | fungal C8-C7 sterol isomerase |
| T15 | 782-791 | DNA | denotes | ERG2 gene |
| T16 | 797-814 | protein | denotes | ERG2 gene product |
| T17 | 969-974 | protein | denotes | SR-BP |
| T18 | 1023-1034 | RNA | denotes | 2 kilobases |
| T19 | 1207-1235 | protein | denotes | specific monoclonal antibody |
| T20 | 1251-1256 | protein | denotes | SR-BP |
| T21 | 1405-1410 | protein | denotes | SR-BP |
| T22 | 1450-1467 | protein | denotes | sigma 1 receptors |
| T23 | 1757-1762 | protein | denotes | SR-BP |
| T24 | 2012-2017 | protein | denotes | SR-BP |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-73 | Sentence | denotes | Purification and characterization of the human SR 31747A-binding protein. |
| S2 | 74-135 | Sentence | denotes | A nuclear membrane protein related to yeast sterol isomerase. |
| S3 | 136-266 | Sentence | denotes | SR 31747A, defined as a sigma ligand, is a novel immunosuppressive agent that blocks proliferation of human and mouse lymphocytes. |
| S4 | 267-391 | Sentence | denotes | Using a radiolabeled chemical probe, we here purified a target of SR 31747A and called it SR 31747A-binding protein (SR-BP). |
| S5 | 392-501 | Sentence | denotes | Purified SR-BP retained its binding properties and migrated on SDS-polyacrylamide gel as a Mr 28,000 protein. |
| S6 | 502-661 | Sentence | denotes | Cloning of the cDNA encoding human SR-BP shows an open reading frame for a 223-amino acid protein, which is homologous to the recently cloned sigma 1 receptor. |
| S7 | 662-792 | Sentence | denotes | Interestingly, the deduced amino acid sequence was found to be related to fungal C8-C7 sterol isomerase, encoded by the ERG2 gene. |
| S8 | 793-942 | Sentence | denotes | The ERG2 gene product has been identified recently as the molecular target of SR 31747A that mediates antiproliferative effects of the drug in yeast. |
| S9 | 943-1146 | Sentence | denotes | Northern blot analysis of SR-BP gene expression revealed a single transcript of 2 kilobases which was widely expressed among organs, with the highest abundance in liver and the lowest abundance in brain. |
| S10 | 1147-1330 | Sentence | denotes | Subcellular localization analysis in various cells, using a specific monoclonal antibody raised against SR-BP, demonstrated that this protein was associated with the nuclear envelope. |
| S11 | 1331-1616 | Sentence | denotes | When studying the binding of SR 31747A on membranes from yeast expressing SR-BP, we found a pharmacological profile of sigma 1 receptors; binding was displaced by (+)-pentazocine, haloperidol, and (+)-SKF 10,047, with (+)-SKF 10, 047 being a more potent competitor than (-)-SKF 10,047. |
| S12 | 1617-1813 | Sentence | denotes | Scatchard plot analysis revealed Kd values of 7.1 nM and 0.15 nM for (+)-pentazocine and SR 31747A, respectively, indicating an affinity of SR-BP 50-fold higher for SR 31747A than for pentazocine. |
| S13 | 1814-1958 | Sentence | denotes | Additionally, we showed that pentazocine, a competitive inhibitor of SR 31747A binding, also prevents the immunosuppressive effect of SR 31747A. |
| S14 | 1959-2135 | Sentence | denotes | Taken together, these findings strongly suggest that SR-BP represents the molecular target for SR 31747A in mammalian tissues, which could be critical for T cell proliferation. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 37-72 | NP | denotes | the human SR 31747A-binding protein |
| C2 | 112-134 | NP | denotes | yeast sterol isomerase |
| C3 | 136-145 | NP | denotes | SR 31747A |
| C4 | 177-208 | NP | denotes | a novel immunosuppressive agent |
| C5 | 209-213 | NP | denotes | that |
| C6 | 221-265 | NP | denotes | proliferation of human and mouse lymphocytes |
| C8 | 333-342 | NP | denotes | SR 31747A |
| C7 | 321-342 | NP | denotes | a target of SR 31747A |
| C9 | 354-356 | NP | denotes | it |
| C10 | 357-390 | NP | denotes | SR 31747A-binding protein (SR-BP) |
| C11 | 392-406 | NP | denotes | Purified SR-BP |
| C12 | 416-419 | NP | denotes | its |
| C13 | 531-542 | NP | denotes | human SR-BP |
| C14 | 575-599 | NP | denotes | a 223-amino acid protein |
| C15 | 601-606 | NP | denotes | which |
| C16 | 677-708 | NP | denotes | the deduced amino acid sequence |
| C17 | 736-765 | NP | denotes | fungal C8-C7 sterol isomerase |
| C18 | 793-814 | NP | denotes | The ERG2 gene product |
| C20 | 871-880 | NP | denotes | SR 31747A |
| C19 | 847-880 | NP | denotes | the molecular target of SR 31747A |
| C21 | 881-885 | NP | denotes | that |
| C22 | 924-932 | NP | denotes | the drug |
| C23 | 1000-1034 | NP | denotes | a single transcript of 2 kilobases |
| C24 | 1035-1040 | NP | denotes | which |
| C25 | 1251-1256 | NP | denotes | SR-BP |
| C26 | 1276-1288 | NP | denotes | this protein |
| C27 | 1360-1369 | NP | denotes | SR 31747A |
| C28 | 1405-1410 | NP | denotes | SR-BP |
| C29 | 1494-1509 | NP | denotes | (+)-pentazocine |
| C30 | 1686-1701 | NP | denotes | (+)-pentazocine |
| C31 | 1706-1715 | NP | denotes | SR 31747A |
| C32 | 1757-1762 | NP | denotes | SR-BP |
| C33 | 1782-1791 | NP | denotes | SR 31747A |
| C34 | 1801-1812 | NP | denotes | pentazocine |
| C35 | 1843-1854 | NP | denotes | pentazocine |
| C36 | 1856-1900 | NP | denotes | a competitive inhibitor of SR 31747A binding |
| C37 | 1948-1957 | NP | denotes | SR 31747A |
| C38 | 2012-2017 | NP | denotes | SR-BP |
| C39 | 2054-2063 | NP | denotes | SR 31747A |
| C40 | 2114-2134 | NP | denotes | T cell proliferation |
| R1 | C5 | C4 | coref-relat | that,a novel immunosuppressive agent |
| R2 | C8 | C3 | coref-ident | SR 31747A,SR 31747A |
| R3 | C7 | C1 | coref-ident | a target of SR 31747A,the human SR 31747A-binding protein |
| R4 | C9 | C7 | coref-pron | it,a target of SR 31747A |
| R5 | C12 | C11 | coref-pron | its,Purified SR-BP |
| R6 | C13 | C10 | coref-ident | human SR-BP,SR 31747A-binding protein (SR-BP) |
| R7 | C15 | C14 | coref-relat | which,a 223-amino acid protein |
| R8 | C16 | C14 | coref-ident | the deduced amino acid sequence,a 223-amino acid protein |
| R9 | C17 | C2 | coref-ident | fungal C8-C7 sterol isomerase,yeast sterol isomerase |
| R10 | C18 | C17 | coref-ident | The ERG2 gene product,fungal C8-C7 sterol isomerase |
| R11 | C20 | C8 | coref-ident | SR 31747A,SR 31747A |
| R12 | C21 | C19 | coref-relat | that,the molecular target of SR 31747A |
| R13 | C22 | C18 | coref-ident | the drug,The ERG2 gene product |
| R14 | C24 | C23 | coref-relat | which,a single transcript of 2 kilobases |
| R15 | C25 | C13 | coref-ident | SR-BP,human SR-BP |
| R16 | C26 | C25 | coref-ident | this protein,SR-BP |
| R17 | C27 | C20 | coref-ident | SR 31747A,SR 31747A |
| R18 | C28 | C26 | coref-ident | SR-BP,this protein |
| R19 | C30 | C29 | coref-ident | (+)-pentazocine,(+)-pentazocine |
| R20 | C31 | C27 | coref-ident | SR 31747A,SR 31747A |
| R21 | C32 | C28 | coref-ident | SR-BP,SR-BP |
| R22 | C33 | C31 | coref-ident | SR 31747A,SR 31747A |
| R23 | C34 | C30 | coref-ident | pentazocine,(+)-pentazocine |
| R24 | C35 | C34 | coref-ident | pentazocine,pentazocine |
| R25 | C36 | C35 | coref-appos | a competitive inhibitor of SR 31747A binding,pentazocine |
| R26 | C37 | C33 | coref-ident | SR 31747A,SR 31747A |
| R27 | C38 | C32 | coref-ident | SR-BP,SR-BP |
| R28 | C39 | C37 | coref-ident | SR 31747A,SR 31747A |
| R29 | C40 | C6 | coref-ident | T cell proliferation,proliferation of human and mouse lymphocytes |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 41-72 | protein_molecule | denotes | human SR 31747A-binding protein |
| T2 | 76-100 | protein_molecule | denotes | nuclear membrane protein |
| T3 | 112-134 | protein_molecule | denotes | yeast sterol isomerase |
| T4 | 136-145 | other_organic_compound | denotes | SR 31747A |
| T5 | 185-208 | other_organic_compound | denotes | immunosuppressive agent |
| T6 | 275-302 | other_organic_compound | denotes | radiolabeled chemical probe |
| T7 | 333-342 | other_organic_compound | denotes | SR 31747A |
| T8 | 357-366 | other_organic_compound | denotes | SR 31747A |
| T9 | 384-389 | protein_molecule | denotes | SR-BP |
| T10 | 392-400 | protein_molecule | denotes | Purified |
| T11 | 401-406 | protein_molecule | denotes | SR-BP |
| T12 | 455-477 | other_organic_compound | denotes | SDS-polyacrylamide gel |
| T13 | 483-500 | protein_molecule | denotes | Mr 28,000 protein |
| T14 | 517-521 | DNA_family_or_group | denotes | cDNA |
| T15 | 531-536 | protein_molecule | denotes | human |
| T16 | 537-542 | protein_molecule | denotes | SR-BP |
| T17 | 552-570 | DNA_domain_or_region | denotes | open reading frame |
| T18 | 577-599 | protein_molecule | denotes | 223-amino acid protein |
| T19 | 644-660 | protein_molecule | denotes | sigma 1 receptor |
| T20 | 736-765 | protein_molecule | denotes | fungal C8-C7 sterol isomerase |
| T21 | 782-791 | DNA_domain_or_region | denotes | ERG2 gene |
| T22 | 797-806 | DNA_domain_or_region | denotes | ERG2 gene |
| T23 | 851-867 | other_name | denotes | molecular target |
| T24 | 871-880 | other_organic_compound | denotes | SR 31747A |
| T25 | 895-920 | other_name | denotes | antiproliferative effects |
| T26 | 936-941 | mono_cell | denotes | yeast |
| T27 | 969-974 | protein_molecule | denotes | SR-BP |
| T28 | 975-990 | other_name | denotes | gene expression |
| T29 | 1023-1034 | RNA_molecule | denotes | 2 kilobases |
| T30 | 1068-1074 | body_part | denotes | organs |
| T31 | 1106-1111 | body_part | denotes | liver |
| T32 | 1140-1145 | body_part | denotes | brain |
| T33 | 1207-1235 | protein_molecule | denotes | specific monoclonal antibody |
| T34 | 1251-1256 | protein_molecule | denotes | SR-BP |
| T35 | 1313-1329 | cell_component | denotes | nuclear envelope |
| T36 | 1360-1369 | other_organic_compound | denotes | SR 31747A |
| T37 | 1373-1382 | cell_component | denotes | membranes |
| T38 | 1388-1393 | mono_cell | denotes | yeast |
| T39 | 1405-1410 | protein_molecule | denotes | SR-BP |
| T40 | 1423-1446 | other_name | denotes | pharmacological profile |
| T41 | 1450-1467 | protein_family_or_group | denotes | sigma 1 receptors |
| T42 | 1494-1509 | other_organic_compound | denotes | (+)-pentazocine |
| T43 | 1511-1522 | other_organic_compound | denotes | haloperidol |
| T44 | 1528-1542 | other_organic_compound | denotes | (+)-SKF 10,047 |
| T45 | 1549-1564 | other_organic_compound | denotes | (+)-SKF 10, 047 |
| T46 | 1601-1615 | other_organic_compound | denotes | (-)-SKF 10,047 |
| T47 | 1617-1640 | other_name | denotes | Scatchard plot analysis |
| T48 | 1686-1701 | other_organic_compound | denotes | (+)-pentazocine |
| T49 | 1706-1715 | other_organic_compound | denotes | SR 31747A |
| T50 | 1757-1762 | protein_molecule | denotes | SR-BP |
| T51 | 1782-1791 | other_organic_compound | denotes | SR 31747A |
| T52 | 1801-1812 | other_organic_compound | denotes | pentazocine |
| T53 | 1843-1854 | other_organic_compound | denotes | pentazocine |
| T54 | 1858-1879 | other_organic_compound | denotes | competitive inhibitor |
| T55 | 1883-1892 | other_organic_compound | denotes | SR 31747A |
| T56 | 1920-1944 | other_name | denotes | immunosuppressive effect |
| T57 | 1948-1957 | other_organic_compound | denotes | SR 31747A |
| T58 | 2012-2017 | protein_molecule | denotes | SR-BP |
| T59 | 2054-2063 | other_organic_compound | denotes | SR 31747A |
| T60 | 2067-2084 | tissue | denotes | mammalian tissues |
| T61 | 2114-2134 | other_name | denotes | T cell proliferation |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 41-46 | OrganismTaxon | denotes | human | 9606 |
| T2 | 238-243 | OrganismTaxon | denotes | human | 9606 |
| T3 | 248-253 | OrganismTaxon | denotes | mouse | 10088|10090 |
| T5 | 531-536 | OrganismTaxon | denotes | human | 9606 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 1106-1111 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/MAT_0000097 |
| T2 | 1140-1145 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/MAT_0000098 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 76-92 | Body_part | denotes | nuclear membrane | http://purl.obolibrary.org/obo/GO_0031965 |
| T2 | 254-265 | Body_part | denotes | lymphocytes | http://purl.obolibrary.org/obo/CL_0000542 |
| T3 | 1106-1111 | Body_part | denotes | liver | http://purl.obolibrary.org/obo/UBERON_0002107 |
| T4 | 1140-1145 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955|http://purl.obolibrary.org/obo/UBERON_6110636 |
| T6 | 1313-1329 | Body_part | denotes | nuclear envelope | http://purl.obolibrary.org/obo/GO_0005635 |
| T7 | 1373-1382 | Body_part | denotes | membranes | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
| T10 | 2114-2120 | Body_part | denotes | T cell | http://purl.obolibrary.org/obo/CL_0000084 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 254-265 | Cell | denotes | lymphocytes | http://purl.obolibrary.org/obo/CL:0000542 |
| T2 | 2114-2120 | Cell | denotes | T cell | http://purl.obolibrary.org/obo/CL:0000084 |